Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) shareholders a week ahead...

|By:, SA News Editor

Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) shareholders a week ahead of a shareholders meeting for the maker of genetic analysis equipment, appears to indicate a willingness to raise its $51/share offer. ILMN shares, -1.6% AH, have been trading above $51 and closed at $52.57 today.